Stereospecific synthesis of tetradeuterated (R)- and (S)-ifosfamide

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 38, Issue 2, 1996, Pages 105-115

  Wang, Jeff J H ^a   Chan, Kenneth K ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Enantiomers; Ifosfamide; Mass spectrometry; Pseudoracemate

Indexed keywords

DRUG PRODUCTS; ENANTIOMERS;

IFOSFAMIDE; ISOTOPE EFFECT; METHYLBENZYLAMINE; MULTISTEPS; PSEUDORACEMATE; RESOLVING AGENTS; STEREO-SELECTIVE; STEREOSPECIFIC SYNTHESIS; SYNTHESISED;

MASS SPECTROMETRY;

DEUTERIUM; IFOSFAMIDE;

ARTICLE; DRUG SYNTHESIS; ENANTIOMER; ISOTOPE LABELING; MASS SPECTROMETRY;

EID: 0030050920     PISSN: 03624803     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1344(199602)38:2<105::AID-JLCR821>3.0.CO;2-X     Document Type: Article

References (24)

1. Ariens E.J. -Med. Res. Rev., 6:451 (1986).
2. Arnold H., Bourseaux F., and Brock N. -Nature, 181:931 (1958).
3. Arnold H., Bourseaux F., and Brock N. -Arzneim.-Forsch., 11:143 (1961).
4. Asia-Werke A.-G. -Chem. Abs., 73:44892d (1970).
5. Sladek N.E. -Pharmacol. Ther., 37:301 (1988).
6. Schoenike S.E. and Dana W.J. -Clin. Pharm., 9:179 (1990).
7. Connors T.A., Cox P.J., Farmer P.B., Foster A.B., and Jarman M. -Biochem. Pharmcol., 23:115 (1974).
8. Allen L.M. and Creaven P.J. -Cancer Chemother. Rep., 56:603 (1972).
9. Takamizawa A., Iwata T., and Matsumoto S. -Chem. Pharm. Bull., 25:2900 (1977).
10. Struck R.F., Dykes D.J., Corbett T.H., Suling W.J., and Trader M.W. -Br. J. Cancer, 47:15 (1983).
11. Bryant B.M., Jarman M., Baker M.H., Smith I.E., and Smyth J.F. -Cancer Res., 40:4734 (1980).
12. Goren M.P. -J. Chromatogr., 570:351 (1991).
13. Goren M.P., Wright R.K., Pratt C.B., and Pell F.E. -Lancet, 2:1219 (1986).
14. Kusnierczyk H., Radzikowski C., Paprocka M., Budzynski W., Rak J., Kinas R., Misiura K., and Stec W. -J. Immunopharmacol., 8:455 (1986).
15. Farmer P.B. -Biochem. Pharmacol., 22:145 (1988).
16. Wainer I.W., Granvil C.P., Wang T., and Batist G. -Cancer Res., 54:4393 (1994).
17. Kaijser G.P., Beijnen J.H., Bult A., and Underberg W.J.M. -Anticancer Res., 14:517 (1994).
18. Misiura K., Okruszek A., Pankiewicz K., Stec W.J., Czownicki Z., and Utracka B. -J. Med. Chem., 26:674 (1983).
19. Trager W.F. -J. Clin. Pharmacol., 26:443 (1986).
20. Cox P.J., Farmer P.B., Foster A.B., Griggs L.J., Jarman M., Kinas R., Pankiewicz K., and Stec WJ. -Biomed. Mass Spectrom., 4:371 (1977).
21. Cox P.J., Farmer P.B., Jarman M., Kinas R.W., and Stec W.J. -Drug Metab. Dispos., 6:617 (1978).
22. Kinas R., Pankiewicz K., Stec W.J., Farmer P.B., Jarman M., and Foster A.B. -Bull. Acad. Pol. Sci., 26:39 (1978).
23. Ludeman S.M., Barlett D.L., and Zon G. -J. Org. Chem., 44:1163 (1979).
24. Pankiewicz K., Kinas R., Stec W.J., Foster A.B., Jarman M., and Van Maanen J.M.S. -J. Am. Chem. Soc., 101:7712 (1979).